CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Impel NeuroPharma Inc.

For profitWebsite ↗

Also known as: Impel NeuroPharma | IMPEL NEUROPHARMA | Impel NeuroPharma Inc. | Impel NeuroPharma, Seattle, WA (USA)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Dec 31, 2021

Timeline

2000s

Jun 1, 2008
Impel NeuroPharma Inc.— Founded

2020s

Sep 2, 2021
dihydroergotamine— Marketing Organization

Drugs by trial phase (3 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

dihydroergotamine

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

dihydroergotamine

Recent trials (8)

NCT05163717Study chairPhase 2Dec 31, 2021
NCT05163717Lead sponsorPhase 2Dec 31, 2021
NCT03624322Study directorPhase 1Aug 5, 2018
NCT03624322Lead sponsorPhase 1Aug 5, 2018
NCT03557333Lead sponsorPhase 3Jul 13, 2018
NCT03541356Study chairPhase 2May 8, 2018
NCT03541356Lead sponsorPhase 2May 8, 2018
NCT03401346Lead sponsorPhase 1Oct 16, 2017

Details

Founded: Seattle, WA, US Jun 1, 2008
Last known activity: Dec 31, 2021